top of page
AdobeStock_134900457-Edit.jpg

AGENDA

Thurs, May 4

Thursday, May 4, 2023

12:00 – 1:00 pm

Registration Open

 

12:45 – 1:00

Welcome to Symposium

Session 1: Opening talk

Moderator: Yves Giguère, CHU de Québec-Université Laval, Québec

1:00 – 2:05       

Keynote: Dr. Dietrich Matern from Mayo Clinic, Minnesota

« Krabbe disease: A fortress with layers of moats, walls and secret passages »

2:05 – 2:30

Question and Answer

2:30 – 3:00

Break

 

Session 2: Tyrosinemia type 1: more than 50 years of experience

Moderator: Guy Parizeault, Saguenay-Lac-St-Jean

3:00 – 5:30

Screening for Tyrosinemia type 1 in Québec: Historical perspective 

Marie-Thérèse Berthier, Yves Giguère, CHU de Québec-Université Laval, Québec

Tyrosinemia type I: Diagnostics and therapeutics

Grant Mitchell, CHU Ste-Justine, Montréal

Family planning: co-creation of a decision support aid to empower couples carrying the tyrosinemia gene

Marie-Ève Poitras/Janick Tremblay, Saguenay-Lac-St-Jean

 

6:00 8:00

Welcome Reception and Poster Viewing

7:00 – 9:00

Garrod Board of Directors Meeting

Friday, May 5, 2023

 

8:00 – 8:30

Breakfast

Session 3: IEMs in Canada Update

Moderators: Paula Waters, CHUS – Sherbrooke, Daniela Buhas, McGill University, Montreal

8:30 – 11:30

Strategies from Coast to Coast: A lifetime journey

11:30 – 12:00

Discussion Panel

12:00 – 1:30 

Lunch and Visit Posters

Session 4:  Poster Presentations What’s new in IEM?

Moderator: Nathalie Lepage, CHEO, Ottawa

1:30 – 3:00  

5 Oral presentations selected from abstract submissions

 

3:00 – 3:30  

Break

 

Session 5: How to beat the every day with an IEM

3:30 – 5:30 

Moderators & Facilitators: Mehdi Yeganeh, CHU de Quebec, Quebec and Ivan Shelihan, MUHC, Montreal

Presenters/testimony and discussion with patients and parents of patients on their experience in the continuum of care.

 

7:30

Gala Awards Dinner

Gala Dinner Location

 

Saturday, May 6, 2023

 

8:00 – 8:30  

Breakfast

Session 6: Allied Health Conference: Treatment of IEM (open to all)

8:30 – 10:30

Moderator: Marie-Helene Bourdages, CHU de Quebec, Quebec

8:30 – 9:15   

Glycerol phenylbutyrate in the treatment of urea cycle disorders with Testimony/exchange of a patient treated during pregnancy

Barbara Burton, Lurie-Children’s Hospital, Chicago

9:15 – 9:30    

Question and Answer

9:30 – 10:15 

Pegvaliase in the treatment of phenylketonuria with Testimony/exchange of a patient
John Mitchell, McGill University, Montreal

10:15 – 10:30

Question and Answer

10:30 – 10:45

Break

 

10:45 – 11:10

Inborn errors of acyl-CoA metabolism

Grant Mitchell, CHU Ste-Justine, Montreal

11:10 – 11:20 

Question and Answer

11:20 – 11:30 

Closing Remarks

Paula Waters, President of Garrod Association

11:30 – 12:55  

Garrod AGM

 

13:00

Lunch with a View

Fri, May 5
Sat, May 6
bottom of page